Copyright Reports & Markets. All rights reserved.

Global Valsartan Drug Sales Market Report 2021

Request for Sample of this report
Buy now

1 Valsartan Drug Market Overview

  • 1.1 Valsartan Drug Product Scope
  • 1.2 Valsartan Drug Segment by Type
    • 1.2.1 Global Valsartan Drug Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 40 mg Tablets
    • 1.2.3 80 mg Tablets
    • 1.2.4 160 mg Tablets
    • 1.2.5 320 mg Tablets
  • 1.3 Valsartan Drug Segment by Application
    • 1.3.1 Global Valsartan Drug Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Hypertension
    • 1.3.3 Heart Failure
    • 1.3.4 Heart Attack
  • 1.4 Valsartan Drug Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Valsartan Drug Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Valsartan Drug Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Valsartan Drug Price Trends (2016-2027)

2 Valsartan Drug Estimates and Forecasts by Region

  • 2.1 Global Valsartan Drug Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Valsartan Drug Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Valsartan Drug Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Valsartan Drug Revenue Market Share by Region (2016-2021)
  • 2.3 Global Valsartan Drug Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Valsartan Drug Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Valsartan Drug Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Valsartan Drug Estimates and Projections (2016-2027)
    • 2.4.2 Europe Valsartan Drug Estimates and Projections (2016-2027)
    • 2.4.3 China Valsartan Drug Estimates and Projections (2016-2027)
    • 2.4.4 Japan Valsartan Drug Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Valsartan Drug Estimates and Projections (2016-2027)
    • 2.4.6 India Valsartan Drug Estimates and Projections (2016-2027)

3 Global Valsartan Drug Competition Landscape by Players

  • 3.1 Global Top Valsartan Drug Players by Sales (2016-2021)
  • 3.2 Global Top Valsartan Drug Players by Revenue (2016-2021)
  • 3.3 Global Valsartan Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Valsartan Drug as of 2020)
  • 3.4 Global Valsartan Drug Average Price by Company (2016-2021)
  • 3.5 Manufacturers Valsartan Drug Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Valsartan Drug Market Size by Type

  • 4.1 Global Valsartan Drug Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Valsartan Drug Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Valsartan Drug Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Valsartan Drug Price by Type (2016-2021)
  • 4.2 Global Valsartan Drug Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Valsartan Drug Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Valsartan Drug Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Valsartan Drug Price Forecast by Type (2022-2027)

5 Global Valsartan Drug Market Size by Application

  • 5.1 Global Valsartan Drug Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Valsartan Drug Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Valsartan Drug Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Valsartan Drug Price by Application (2016-2021)
  • 5.2 Global Valsartan Drug Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Valsartan Drug Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Valsartan Drug Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Valsartan Drug Price Forecast by Application (2022-2027)

6 North America Valsartan Drug Market Facts & Figures

  • 6.1 North America Valsartan Drug Sales by Company
    • 6.1.1 North America Valsartan Drug Sales by Company (2016-2021)
    • 6.1.2 North America Valsartan Drug Revenue by Company (2016-2021)
  • 6.2 North America Valsartan Drug Sales Breakdown by Type
    • 6.2.1 North America Valsartan Drug Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Valsartan Drug Sales Breakdown by Type (2022-2027)
  • 6.3 North America Valsartan Drug Sales Breakdown by Application
    • 6.3.1 North America Valsartan Drug Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Valsartan Drug Sales Breakdown by Application (2022-2027)

7 Europe Valsartan Drug Market Facts & Figures

  • 7.1 Europe Valsartan Drug Sales by Company
    • 7.1.1 Europe Valsartan Drug Sales by Company (2016-2021)
    • 7.1.2 Europe Valsartan Drug Revenue by Company (2016-2021)
  • 7.2 Europe Valsartan Drug Sales Breakdown by Type
    • 7.2.1 Europe Valsartan Drug Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Valsartan Drug Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Valsartan Drug Sales Breakdown by Application
    • 7.3.1 Europe 135 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 135 Sales Breakdown by Application (2022-2027)

8 China Valsartan Drug Market Facts & Figures

  • 8.1 China Valsartan Drug Sales by Company
    • 8.1.1 China Valsartan Drug Sales by Company (2016-2021)
    • 8.1.2 China Valsartan Drug Revenue by Company (2016-2021)
  • 8.2 China Valsartan Drug Sales Breakdown by Type
    • 8.2.1 China Valsartan Drug Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Valsartan Drug Sales Breakdown by Type (2022-2027)
  • 8.3 China Valsartan Drug Sales Breakdown by Application
    • 8.3.1 China 163 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 163 Sales Breakdown by Application (2022-2027)

9 Japan Valsartan Drug Market Facts & Figures

  • 9.1 Japan Valsartan Drug Sales by Company
    • 9.1.1 Japan Valsartan Drug Sales by Company (2016-2021)
    • 9.1.2 Japan Valsartan Drug Revenue by Company (2016-2021)
  • 9.2 Japan Valsartan Drug Sales Breakdown by Type
    • 9.2.1 Japan Valsartan Drug Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Valsartan Drug Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Valsartan Drug Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Valsartan Drug Market Facts & Figures

  • 10.1 Southeast Asia Valsartan Drug Sales by Company
    • 10.1.1 Southeast Asia Valsartan Drug Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Valsartan Drug Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Valsartan Drug Sales Breakdown by Type
    • 10.2.1 Southeast Asia Valsartan Drug Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Valsartan Drug Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Valsartan Drug Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Valsartan Drug Market Facts & Figures

  • 11.1 India Valsartan Drug Sales by Company
    • 11.1.1 India Valsartan Drug Sales by Company (2016-2021)
    • 11.1.2 India Valsartan Drug Revenue by Company (2016-2021)
  • 11.2 India Valsartan Drug Sales Breakdown by Type
    • 11.2.1 India Valsartan Drug Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Valsartan Drug Sales Breakdown by Type (2022-2027)
  • 11.3 India Valsartan Drug Sales Breakdown by Application
    • 11.3.1 India Valsartan Drug Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Valsartan Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Valsartan Drug Business

  • 12.1 Novartis
    • 12.1.1 Novartis Corporation Information
    • 12.1.2 Novartis Business Overview
    • 12.1.3 Novartis Valsartan Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Novartis Valsartan Drug Products Offered
    • 12.1.5 Novartis Recent Development
  • 12.2 Sun Pharmaceutical
    • 12.2.1 Sun Pharmaceutical Corporation Information
    • 12.2.2 Sun Pharmaceutical Business Overview
    • 12.2.3 Sun Pharmaceutical Valsartan Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Sun Pharmaceutical Valsartan Drug Products Offered
    • 12.2.5 Sun Pharmaceutical Recent Development
  • 12.3 Teva
    • 12.3.1 Teva Corporation Information
    • 12.3.2 Teva Business Overview
    • 12.3.3 Teva Valsartan Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Teva Valsartan Drug Products Offered
    • 12.3.5 Teva Recent Development
  • 12.4 Mylan
    • 12.4.1 Mylan Corporation Information
    • 12.4.2 Mylan Business Overview
    • 12.4.3 Mylan Valsartan Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Mylan Valsartan Drug Products Offered
    • 12.4.5 Mylan Recent Development
  • 12.5 Alembic Pharmaceuticals
    • 12.5.1 Alembic Pharmaceuticals Corporation Information
    • 12.5.2 Alembic Pharmaceuticals Business Overview
    • 12.5.3 Alembic Pharmaceuticals Valsartan Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Alembic Pharmaceuticals Valsartan Drug Products Offered
    • 12.5.5 Alembic Pharmaceuticals Recent Development
  • 12.6 Lupin
    • 12.6.1 Lupin Corporation Information
    • 12.6.2 Lupin Business Overview
    • 12.6.3 Lupin Valsartan Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Lupin Valsartan Drug Products Offered
    • 12.6.5 Lupin Recent Development
  • 12.7 Aurobindo Pharma
    • 12.7.1 Aurobindo Pharma Corporation Information
    • 12.7.2 Aurobindo Pharma Business Overview
    • 12.7.3 Aurobindo Pharma Valsartan Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Aurobindo Pharma Valsartan Drug Products Offered
    • 12.7.5 Aurobindo Pharma Recent Development
  • 12.8 Macleods Pharmaceuticals
    • 12.8.1 Macleods Pharmaceuticals Corporation Information
    • 12.8.2 Macleods Pharmaceuticals Business Overview
    • 12.8.3 Macleods Pharmaceuticals Valsartan Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Macleods Pharmaceuticals Valsartan Drug Products Offered
    • 12.8.5 Macleods Pharmaceuticals Recent Development
  • 12.9 HETERO
    • 12.9.1 HETERO Corporation Information
    • 12.9.2 HETERO Business Overview
    • 12.9.3 HETERO Valsartan Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 HETERO Valsartan Drug Products Offered
    • 12.9.5 HETERO Recent Development
  • 12.10 Torrent Pharmaceuticals
    • 12.10.1 Torrent Pharmaceuticals Corporation Information
    • 12.10.2 Torrent Pharmaceuticals Business Overview
    • 12.10.3 Torrent Pharmaceuticals Valsartan Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 Torrent Pharmaceuticals Valsartan Drug Products Offered
    • 12.10.5 Torrent Pharmaceuticals Recent Development
  • 12.11 Huaren Pharmaceutical
    • 12.11.1 Huaren Pharmaceutical Corporation Information
    • 12.11.2 Huaren Pharmaceutical Business Overview
    • 12.11.3 Huaren Pharmaceutical Valsartan Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 Huaren Pharmaceutical Valsartan Drug Products Offered
    • 12.11.5 Huaren Pharmaceutical Recent Development
  • 12.12 Jubilant Pharma
    • 12.12.1 Jubilant Pharma Corporation Information
    • 12.12.2 Jubilant Pharma Business Overview
    • 12.12.3 Jubilant Pharma Valsartan Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.12.4 Jubilant Pharma Valsartan Drug Products Offered
    • 12.12.5 Jubilant Pharma Recent Development
  • 12.13 Amneal Pharmaceuticals
    • 12.13.1 Amneal Pharmaceuticals Corporation Information
    • 12.13.2 Amneal Pharmaceuticals Business Overview
    • 12.13.3 Amneal Pharmaceuticals Valsartan Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.13.4 Amneal Pharmaceuticals Valsartan Drug Products Offered
    • 12.13.5 Amneal Pharmaceuticals Recent Development
  • 12.14 Zhejiang Huahai Pharmaceutical
    • 12.14.1 Zhejiang Huahai Pharmaceutical Corporation Information
    • 12.14.2 Zhejiang Huahai Pharmaceutical Business Overview
    • 12.14.3 Zhejiang Huahai Pharmaceutical Valsartan Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.14.4 Zhejiang Huahai Pharmaceutical Valsartan Drug Products Offered
    • 12.14.5 Zhejiang Huahai Pharmaceutical Recent Development
  • 12.15 Square Pharmaceuticals
    • 12.15.1 Square Pharmaceuticals Corporation Information
    • 12.15.2 Square Pharmaceuticals Business Overview
    • 12.15.3 Square Pharmaceuticals Valsartan Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.15.4 Square Pharmaceuticals Valsartan Drug Products Offered
    • 12.15.5 Square Pharmaceuticals Recent Development
  • 12.16 Unichem Laboratories
    • 12.16.1 Unichem Laboratories Corporation Information
    • 12.16.2 Unichem Laboratories Business Overview
    • 12.16.3 Unichem Laboratories Valsartan Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.16.4 Unichem Laboratories Valsartan Drug Products Offered
    • 12.16.5 Unichem Laboratories Recent Development

13 Valsartan Drug Manufacturing Cost Analysis

  • 13.1 Valsartan Drug Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Valsartan Drug
  • 13.4 Valsartan Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Valsartan Drug Distributors List
  • 14.3 Valsartan Drug Customers

15 Market Dynamics

  • 15.1 Valsartan Drug Market Trends
  • 15.2 Valsartan Drug Drivers
  • 15.3 Valsartan Drug Market Challenges
  • 15.4 Valsartan Drug Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    The global Valsartan Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Valsartan Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

    Segment by Type
    40 mg Tablets
    80 mg Tablets
    160 mg Tablets
    320 mg Tablets

    Segment by Application
    Hypertension
    Heart Failure
    Heart Attack

    The Valsartan Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Valsartan Drug market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

    By Company
    Novartis
    Sun Pharmaceutical
    Teva
    Mylan
    Alembic Pharmaceuticals
    Lupin
    Aurobindo Pharma
    Macleods Pharmaceuticals
    HETERO
    Torrent Pharmaceuticals
    Huaren Pharmaceutical
    Jubilant Pharma
    Amneal Pharmaceuticals
    Zhejiang Huahai Pharmaceutical
    Square Pharmaceuticals
    Unichem Laboratories

    Buy now